Renlo Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: flat dose pricing with the pharmacy and medical group named
Renlo Health scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Renlo Health is a telehealth platform selling compounded semaglutide at $199/mo and compounded tirzepatide at $269/mo, flat at every dose, with medication, injection supplies, provider care and expedited shipping in one monthly price and no membership fee. It names both its prescribing medical group and its dispensing pharmacy, and adds NAD+ and glutathione injections as separate longevity products.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Renlo Health
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
Editorial score · methodology
Renlo Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Renlo Health
Each dimension is scored algorithmically from Renlo Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $199/mo, Renlo Health runs about 17% above the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Renlo Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.7/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.6/10Renlo Health treats patients in all 50 states.
Support10%
6.2/10Renlo Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Renlo Health review
Last checked September 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$269/mo across 2 dose/plan tiers — checked September 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Renlo Health
We walked Renlo Health’s public signup flow in September 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Prices are public first: the semaglutide and tirzepatide pages post $199/mo and $269/mo, each with a three-column 'Starting dose / Mid dose / Higher dose' panel showing the same number three times, before you start anything.
- 2The intake opens on a four-step progress bar headed '2-minute visit · Only charged if prescribed' and asks your weight-loss goal.
- 3Step two takes your date of birth.
- 4Step three asks sex assigned at birth, described as needed 'for your doctor to make medical decisions'.
- 5Step four asks for your mobile number and ZIP code. Continuing here opts you into SMS. We stopped at that gate.
- Renlo publishes what most compounded sellers hide: a named prescribing group (Arora Health & Aesthetics, LLC, 300 Lenora Street, Seattle) and a named dispensing pharmacy (VialsRx, 6220 Westpark Dr, Houston), both on a linked compliance page rather than buried in the terms.
- The dose-pricing claim is unusually concrete — the product pages print the same figure at starting, mid and higher dose next to '$0 increase, at every dose', rather than a vague 'one price' line.
- The four-month money-back guarantee is real but conditional: a documented baseline weigh-in within 14 days of your first prescription, a second weigh-in inside a 28-day window around the four-month mark, continuous enrollment, full adherence, and a request filed within 14 days after that. Miss any of it and the standing rule is that all sales are final.
- The step-four screen states 'By continuing, you agree to receive texts about your order and care' with no way to decline and continue.
- No phone number appears anywhere on the site, on the compliance page or in the intake footer, although the homepage advertises '24/7 concierge support'.
- A limited-time banner offers code RENLO50 for $50 off to the 'NEXT 20 PATIENTS' — a scarcity device with no counter behind it.
Renlo Health customer support
- Hours
- Advertised as 24/7 concierge support; no hours or phone number published
GLP-1 medications Renlo Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Renlo Health offers
Beyond GLP-1s, Renlo Health also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
'$199/mo' against a struck-through '$299'; '$199 Starting dose / $199 Mid dose / $199 Higher dose'.
'$269/mo' against a struck-through '$399'; 'Your price stays flat', '$0 increase, at every dose'.
Ready to get started?
Plans and promotions change often — check Renlo Health's current pricing and active discounts before you decide.
What we like
- Flat pricing published before intake: semaglutide $199/mo, tirzepatide $269/mo, same price at every dose
- Names its prescribing medical group (Arora Health & Aesthetics, LLC, Seattle) and its dispensing pharmacy (VialsRx, Houston)
- Two named physicians front the clinical side, both identified by name and role
- One price covers medication, injection supplies, provider evaluation, ongoing care and expedited shipping
- No membership or consultation fee, and 'Cancel anytime, no fee'
- LegitScript seal is served from LegitScript's own CDN, not self-hosted
- You are only charged if a provider prescribes; not approved means a full refund
Watch-outs
- Tirzepatide at $269/mo sits well above the compounded market's cheaper end
- The four-month money-back guarantee is narrow — two timed weight verifications, unbroken enrollment, full adherence, and under 2% lost
- Outside that guarantee 'all sales are final' — no returns on prescription products
- No phone number is published; support is email only, despite a '24/7 concierge support' claim
- The intake asks for your mobile number and opts you into SMS before it will go further
- The all-50-states claim comes with a caveat that medications and fulfillment vary by state
- Compounded semaglutide and tirzepatide are not FDA-approved
Is Renlo Health worth it?
Renlo Health built its program around one core idea: flat dose pricing with the pharmacy and medical group named. It runs $199/month, the same price at every dose, — a premium versus the rest of the category, so its specific extras need to earn that difference. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Worth knowing before you sign up: Renlo Health is LegitScript-certified and offers NAD+ or peptide add-ons.
How much Renlo Health actually costs
Compounded semaglutide runs $199/month and compounded tirzepatide runs $269/month.
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month. Renlo Health's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against Renlo Health before you commit.
Medications: what Renlo Health prescribes
Renlo Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Renlo Health is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Renlo Health treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Renlo Health costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, HumeCare+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Renlo Health scores highest on state availability and ease of access.
Ready to start with Renlo Health?
Starting at $199/month. See current pricing and start your free consultation.
Renlo Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Renlo Health review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Renlo Health's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.